Compounds > dehydroepiandrosterone sulfate
Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and cyclosporine

dehydroepiandrosterone sulfate has been researched along with cyclosporine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L1
Bartoli, E; Ferraccioli, G; Guerra, P; Rizzi, V1
Bartoli, E; Casatta, L; Ferraccioli, G1
Chartrand, C; Chartrand, S; De Broux, E; Dupuis, C; Huot, C; Vobecky, S1
Häusler, S; Schneiter, R; Stieger, B; Treiber, A1

Reviews

1 review(s) available for dehydroepiandrosterone sulfate and cyclosporine

ArticleYear
Membrane transporters in drug development.
    Nature reviews. Drug discovery, 2010, Volume: 9, Issue:3

    Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs

2010

Trials

1 trial(s) available for dehydroepiandrosterone sulfate and cyclosporine

ArticleYear
Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases.
    The Journal of rheumatology, 1995, Volume: 22, Issue:6

    Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteocalcin

1995

Other Studies

4 other study(ies) available for dehydroepiandrosterone sulfate and cyclosporine

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy.
    The Journal of rheumatology, 1996, Volume: 23, Issue:9

    Topics: Acute-Phase Proteins; Arthritis, Rheumatoid; Bone Density; C-Reactive Protein; Cyclosporine; Dehydroepiandrosterone Sulfate; Drug Resistance; Female; Humans; Insulin-Like Growth Factor I; Joints; Male; Methotrexate; Middle Aged; Osteocalcin; Retreatment

1996
[Pubertal development after pediatric heart transplantation].
    Annales de chirurgie, 1996, Volume: 50, Issue:8

    Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Dehydroepiandrosterone Sulfate; Female; Gonadotropins, Pituitary; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Prednisone; Prospective Studies; Puberty; Sex Factors; Testosterone

1996
Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:8

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biological Transport; Bosentan; CHO Cells; Cricetinae; Cricetulus; Cyclosporine; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone Sulfate; Drug Interactions; Enzyme Inhibitors; Estradiol; Estrone; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Piperazines; Purines; Pyrimidines; Rifampin; Sildenafil Citrate; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides; Sulfones; Warfarin

2007